DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mi

DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mi

Item
http://www.wikidata.org/entity/Q27473069
Evaluating Replication-Defective Vesicular Stomatitis Virus as a Vaccine VehicleEvidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia VirusElicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal modelsDNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB/c miceProgress on new vaccine strategies against chronic viral infectionsEvaluation of the immunogenicity of liposome encapsulated HVR1 and NS3 regions of genotype 3 HCV, either singly or in combinationDevelopment of prophylactic and therapeutic vaccines against hepatitis C virus.Ever closer to a prophylactic vaccine for HCV.Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus.Mycobacterium tuberculosis culture filtrate proteins plus CpG Oligodeoxynucleotides confer protection to Mycobacterium bovis BCG-primed mice by inhibiting interleukin-4 secretion.Needle-free delivery of macromolecules through the skin using controllable jet injectors.Progress in the development of vaccines for hepatitis C virus infection.Methods to Evaluate Novel Hepatitis C Virus Vaccines.A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus.Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity.Prime-boost vaccination based on DNA and protein-loaded microspheres for tuberculosis prevention.
P2860

DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mi

Item
http://www.wikidata.org/entity/Q27473069
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
DNA immunization with hepatiti ...... tion in HLA-A2.1-transgenic mi
@ast
DNA immunization with hepatiti ...... tion in HLA-A2.1-transgenic mi
@en
DNA immunization with hepatiti ...... tion in HLA-A2.1-transgenic mi
@nl
type
label
DNA immunization with hepatiti ...... tion in HLA-A2.1-transgenic mi
@ast
DNA immunization with hepatiti ...... tion in HLA-A2.1-transgenic mi
@en
DNA immunization with hepatiti ...... tion in HLA-A2.1-transgenic mi
@nl
prefLabel
DNA immunization with hepatiti ...... tion in HLA-A2.1-transgenic mi
@ast
DNA immunization with hepatiti ...... tion in HLA-A2.1-transgenic mi
@en
DNA immunization with hepatiti ...... tion in HLA-A2.1-transgenic mi
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
DNA immunization with hepatiti ...... tion in HLA-A2.1-transgenic mi
@en
P2093
P2860
P304
P31
P356
10.1128/JVI.77.1.382-390.2003
P433
P478
P577
P5875
P698
P921
P932